Emerging findings have demonstrated that autocrine VEGF-VEGFR2 signalling serves as an angiogenic modulator that controls tumorigenesis and malignant behaviour in many cancer cells, including ovarian cancer and skin epithelial cancer 11, 16-18, 21. This evidence concerns the gene VEGFA and ovarian carcinoma.